NPKYY (NPKYY) Stock Price & Analysis

NPKYY (NPKYY) rose 0.00% to USD 13.16 as of June 10, 2026 at 07:32 UTC, according to Nexqual real-time market data.

NPKYY last closed at USD 13.16; the session ranged USD 13.16–13.16 on volume of 411 shares. Market capitalization is $1.95B, with a 52-week range of USD 8.46–13.16 (PNK). Source: Nexqual, June 10, 2026 at 07:32 UTC.

Key Statistics (as of June 10, 2026 at 07:32 UTC)

PriceUSD 13.16
Change▲ 0.00% (up)
Previous CloseUSD 13.16
OpenUSD 13.16
Day RangeUSD 13.16 – 13.16
52-Week RangeUSD 8.46 – 13.16
Volume411 shares
Market Cap$1.95B
ExchangePNK

Technical Analysis (NPKYY)

Nexqual's technical model rates NPKYY "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 07:32 UTC.

Overall SignalBUY
RSI (14)100 (overbought)
vs SMA50Above (USD 12)
MACD0.39 (positive)

Analyst Ratings (NPKYY)

Wall Street analysts rate NPKYY "None", per Nexqual as of June 10, 2026 at 07:32 UTC.

Consensus RatingNone

Earnings (NPKYY)

Revenue Estimate$69.50B

Source: Nexqual, June 10, 2026 at 07:32 UTC.

Financials & Fundamentals (NPKYY)

Total Revenue$241.85B
Revenue Growth (YoY)+23.10%
Gross Margin+30.13%
Operating Margin+9.12%
Profit Margin+10.19%
ROE+9.01%
Debt / Equity17.56
Current Ratio3.38
Total Cash$54.49B
Total Debt$49.18B
Free Cash Flow$-8.27B

Source: Nexqual, June 10, 2026 at 07:32 UTC.

Financial Health Score (NPKYY)

Nexqual rates NPKYY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:32 UTC.

GrowthCritical — Revenue -35% YoY (annual), sharp decline
ProfitabilitySolid — Gross margin 30%, operating 9%
Balance SheetStrong — $54.5B cash vs $49.2B debt, net cash position
Cash FlowWeak — FCF negative: -$8.27B, burning cash
EfficiencyMixed — ROE 9%, ROA 3.6%

Ownership (NPKYY)

Shares Outstanding148.49M
Float133.62M

Source: Nexqual, June 10, 2026 at 07:32 UTC.

Leadership (NPKYY)

NPKYY is led by Shigeyuki Kawamura (age 62), President, CEO & Director, per Nexqual as of June 10, 2026 at 07:32 UTC.

President, CEO & DirectorShigeyuki Kawamura (age 62)
MD of Technology & DirectorYasuhito Kato (age 60)
Senior Executive Officer of planning, Corp. Communication & Accounting and DirectorShinji Inoue (age 59)
MD of Human Resource & DirectorMakoto Takeda (age 61)
Senior MD, Head of Pharmaceuticals Group & DirectorHiroshi Shimada (age 60)

Peers & Related Stocks

SymbolNamePriceChange
NPSKYNSK Ltd.USD 14.38▲ 0%
MTLHYMitsubishi Chemical Group CorpoUSD 36.84▲ 6.17%
NNCHYNissan Chemical CorporationUSD 48.86▲ 0%
MAUSYMATSUI SECURITIES CO ADR EACH RUSD 11.45▲ 0%
NIFCYNIFCO INC UNSP ADR EACH REP 0.5USD 13.23▲ 0%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:32 UTC. This page is informational and not investment advice.